Delivery Order SPE2DR25D1109-SPE2DR26FFF5D
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units) valued at $1,979.60. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction. The order is scheduled for ultimate completion by September 16, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,431.02 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 40 mg capsules (30-count) with an ultimate completion date of September 11, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Duloxetine HCl DR 40 mg capsules (30-count) with a ceiling value of $1,110.54. The award was made on July 22, 2025, under a firm fixed-price delivery order contract with an ultimate completion date of July 23, 2025. This non-set-aside award represents a competitive procurement and will be performed at the vendor's Conshohocken...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (90-count units) valued at $3,416.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 24, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the open competition procurement process....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of 1,000 units of Duloxetine HCL DR 60 mg capsules at a ceiling value of $1,433.94. This is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,919.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of 1,000 capsules of Duloxetine HCL DR 20 mg. This non-set-aside contract, which is due for completion by August 13, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count packaging) with a ceiling value of $1,320.72. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The order has an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,170.96 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Duloxetine HCL DR 60 mg capsules (1,000 units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set for completion by September 2, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,084.80 to AmerisourceBergen Drug Corp for Duloxetine HCL DR 40 mg capsules (30-count) on August 15, 2025, with completion expected by August 18, 2025. This firm fixed-price, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a routine pharmaceutical procurement fulfilling federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Duloxetine HCL DR 60 mg capsules (1,000 units) with a ceiling value of $3,245.94. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 25, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting AmerisourceBergen's...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFF5DDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count unit) with a ceiling value of $1,487.88. This non-set-aside, firm fixed-price delivery order is scheduled for completion by October 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply agreement running through December 2026 that enables the company to provide a wide range of medications and medical supplies to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor within the Defense Logistics Agency's Medical Supply Chain. The company maintains a substantial portfolio of federal contracts for pharmaceutical products across multiple therapeutic domains, including neurological treatments, pain management, and specialty medications. This delivery order for Duloxetine HCL, an antidepressant and pain management medication commonly used in military and veteran healthcare systems, exemplifies the company's role in supplying essential medications to support Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/23/25 |